168 related articles for article (PubMed ID: 31953828)
1. Application of Metabolomics to Renal and Cardiometabolic Diseases.
Rebholz CM; Rhee EP
Methods Mol Biol; 2020; 2104():401-417. PubMed ID: 31953828
[TBL] [Abstract][Full Text] [Related]
2. A practical guide to metabolomic profiling as a discovery tool for human heart disease.
Heather LC; Wang X; West JA; Griffin JL
J Mol Cell Cardiol; 2013 Feb; 55():2-11. PubMed ID: 23231771
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention.
Dubin RF; Rhee EP
Clin J Am Soc Nephrol; 2020 Mar; 15(3):404-411. PubMed ID: 31636087
[TBL] [Abstract][Full Text] [Related]
4. An overview of renal metabolomics.
Kalim S; Rhee EP
Kidney Int; 2017 Jan; 91(1):61-69. PubMed ID: 27692817
[TBL] [Abstract][Full Text] [Related]
5. Linking of metabolomic biomarkers with cardiometabolic health in Chinese population.
Sun L; Li H; Lin X
J Diabetes; 2019 Apr; 11(4):280-291. PubMed ID: 30239137
[TBL] [Abstract][Full Text] [Related]
6. Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.
Wang Q; McCormick TS; Ward NL; Cooper KD; Conic R; Xu R
AMIA Annu Symp Proc; 2017; 2017():1734-1743. PubMed ID: 29854244
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.
Ho JE; Larson MG; Ghorbani A; Cheng S; Chen MH; Keyes M; Rhee EP; Clish CB; Vasan RS; Gerszten RE; Wang TJ
PLoS One; 2016; 11(2):e0148361. PubMed ID: 26863521
[TBL] [Abstract][Full Text] [Related]
8. Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
Cheng S; Shah SH; Corwin EJ; Fiehn O; Fitzgerald RL; Gerszten RE; Illig T; Rhee EP; Srinivas PR; Wang TJ; Jain M;
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28360086
[TBL] [Abstract][Full Text] [Related]
9. Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook.
Dunn WB; Goodacre R; Neyses L; Mamas M
Bioanalysis; 2011 Oct; 3(19):2205-22. PubMed ID: 21985415
[TBL] [Abstract][Full Text] [Related]
10. Metabolome and microbiome in kidney diseases.
Vairakkani R; Fernando ME; Raj TY
Saudi J Kidney Dis Transpl; 2020; 31(1):1-9. PubMed ID: 32129192
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics in the study of kidney diseases.
Weiss RH; Kim K
Nat Rev Nephrol; 2011 Oct; 8(1):22-33. PubMed ID: 22025087
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics and Metabolic Diseases: Where Do We Stand?
Newgard CB
Cell Metab; 2017 Jan; 25(1):43-56. PubMed ID: 28094011
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics to reveal biomarkers and pathways of preterm birth: a systematic review and epidemiologic perspective.
Carter RA; Pan K; Harville EW; McRitchie S; Sumner S
Metabolomics; 2019 Sep; 15(9):124. PubMed ID: 31506796
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics and mitochondrial dysfunction in cardiometabolic disease.
Shastry A; Dunham-Snary K
Life Sci; 2023 Nov; 333():122137. PubMed ID: 37788764
[TBL] [Abstract][Full Text] [Related]
15. Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics.
Mastrangelo A; Barbas C
Adv Exp Med Biol; 2017; 965():235-263. PubMed ID: 28132183
[TBL] [Abstract][Full Text] [Related]
16. Application of Metabolomics in Lung Research.
Reisdorph NA; Cruickshank-Quinn C; Nkrumah-Elie Y; Reisdorph R
Methods Mol Biol; 2018; 1809():263-288. PubMed ID: 29987794
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics in chronic kidney disease.
Zhao YY
Clin Chim Acta; 2013 Jun; 422():59-69. PubMed ID: 23570820
[TBL] [Abstract][Full Text] [Related]
18. Urinary metabonomics elucidate the therapeutic mechanism of Orthosiphon stamineus in mouse crystal-induced kidney injury.
Gao S; Chen W; Peng Z; Li N; Su L; Lv D; Li L; Lin Q; Dong X; Guo Z; Lou Z
J Ethnopharmacol; 2015 May; 166():323-32. PubMed ID: 25794803
[TBL] [Abstract][Full Text] [Related]
19. Nutritional Metabolomics in Cancer Epidemiology: Current Trends, Challenges, and Future Directions.
McGee EE; Kiblawi R; Playdon MC; Eliassen AH
Curr Nutr Rep; 2019 Sep; 8(3):187-201. PubMed ID: 31129888
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
